Home

The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.

About


The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.

IDCRC Active & Completed Studies
IDCRC Logo

Deadline extended! Submit a nomination for the 2024 Annual IDCRC Awards

The IDCRC presents annual awards to acknowledge the work of VTEU members who have made exceptional contributions to the IDCRC and VTEU missions. We are now taking nominations for 2024. Nominations can be made by any IDCRC LG or VTEU member. Nominators may submit a nomination for each award category. All nominations must be received by Friday, March 8, 2024.

LEARN MORE & SUBMIT
2023 annual award winners

COVID-19 Vaccination and Boosting During Pregnancy Protects Infants for Six Months

Results from the Multisite Observational Maternal and Infant COVID-19 Vaccine (MOMI-Vax) study revealed that when pregnant volunteers received both doses of an mRNA COVID-19 vaccine, antibodies induced by the vaccine could be found in their newborns’ cord blood. This suggested that the infants likely had some protection against COVID-19 when they were still too young to receive a vaccine. Researchers at the NIAID-funded IDCRC, which conducted the study, did not know how long these antibody levels would last or how well the infants would actually be protected. The research team hoped to gather this information by following the infants through their first six months of life.

Read More
COVID-19 Vaccination and Boosting During Pregnancy Protects Infants for Six Months

COVID-19 Prevention Network

The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.

More about the CoVPN
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies

IDCRC Sites Across the Nation


IDCRC Leadership Group

Emory University School of Medicine

University of Maryland Baltimore

Baylor College of Medicine

Cincinnati Children’s Hospital Medical Center

FHI 360

Fred Hutch

University of Alabama School of Medicine

Johns Hopkins School of Medicine

Vanderbilt University Medical Center

University of Washington

IDCRC Vaccine & Treatment Evaluation Units (VTEUs)

IDCRC Concept Quick Stats

ICP Status

  • Approved: 55
  • Administratively Not Supported: 29
  • Not Approved: 51
  • EWG Review: 2
  • EWG Liaisons: 0
  • EMT Concurrence: 0
  • Withdrawn: 15
  • Hold: 0
  • Moved to Active Study: 2

EWG Assignment

  • COVID: 92
  • Respiratory: 26
  • Emerging Infections: 13
  • Enteric Infections: 7
  • Malaria/Topical Diseases: 13
  • STI: 15

ECP

  • EWG Review-In Process: 3
  • EMT Review: 2
  • Approved-moved to Prioritization: 5
  • Not Approved: 14
  • Approved-moved to Protocol Development: 2
  • Active Study: 6
  • EMT Vote: 0
  • Study in Protocol Development: 5
  • Study Closed (LSLV Complete): 4
  • Other: 9

IDCRC Citation Statement


Please include the following citation in any publications resulting from direct or indirect IDCRC support:

"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

 

Publications